Dergiler / Turkish Journal of Biology / 2021 / Cilt: 45 - Sayı: 3

Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy

Sayfa
323–332
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Metabolite set enrichment analysis (MSEA) of those significant predictors (p < 0.05) mapped butyrate metabolism as highly influential pathway in NAC, with arginine-proline metabolism and branched chain amino acid (BCAA) degradation as common pathways in both models, thus providing new insights towards initial metabolic remodeling in the pathogenesis of CH.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cardiac hypertrophy (CH), leading to cardiac failure is due to chronic metabolic alterations occurring during cellular stress.
📊
Temel Bulgular & Veri:The main objective was to identify serum metabolites that can serve as potent predictors for seven routine clinical and diagnostic parameters in CH: 3-hydroxybutyrate (3-HB), lactic acid (LA), urea, and ECG-CH parameters (QRS complex, R-amplitude, R-R interval, heart rate) that were hypothesized to underlie metabolic remodelling in this study.
💡
Sonuç & Katkı:Metabolite set enrichment analysis (MSEA) of those significant predictors (p < 0.05) mapped butyrate metabolism as highly influential pathway in NAC, with arginine-proline metabolism and branched chain amino acid (BCAA) degradation as common pathways in both models, thus providing new insights towards initial metabolic remodeling in the pathogenesis of CH.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Cardiac hypertrophy (CH), leading to cardiac failure is due to chronic metabolic alterations occurring during cellular stress. Besides the already known relationship between oxidative stress and CH, there are implications of reductive stress leading to CH. This study attempted to develop reductive stress-based CH rat model using n-acetyl-L-cysteine (NAC), a glutathione agonist that was compared with typical isoproterenol (ISO) induced CH model. The main objective was to identify serum metabolites that can serve as potent predictors for seven routine clinical and diagnostic parameters in CH: 3-hydroxybutyrate (3-HB), lactic acid (LA), urea, and ECG-CH parameters (QRS complex, R-amplitude, R-R interval, heart rate) that were hypothesized to underlie metabolic remodelling in this study. CH was assessed using electrocardiography, hypertrophic index and histopathological analysis (H&E stain) in both ventricles after 2 weeks. Gas chromatography mass spectroscopy analysis (GC-MS) identified unique metabolite finger-prints. Correlation and pattern analysis revealed strong relationships between specific metabolites and parameters (Pearson’s score > 0.7) of this study. Multiple regression analysis (MRA) for the strongly related metabolites (independent variables) with each of the seven parameters (dependent variables) identified significant predictors for the latter namely fructose, valine, butanoic acid in NAC and cholesterol, erythrose, isoleucine in ISO models, with proline and succinic acid as common for both models. Metabolite set enrichment analysis (MSEA) of those significant predictors (p < 0.05) mapped butyrate metabolism as highly influential pathway in NAC, with arginine-proline metabolism and branched chain amino acid (BCAA) degradation as common pathways in both models, thus providing new insights towards initial metabolic remodeling in the pathogenesis of CH.

🔖

Bu Makaleye Atıf Yap

KUBERAPANDIAN, D., DOSS, V. A. (2022). Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy. Turkish Journal of Biology, Cilt: 45 - Sayı: 3, 323–332. https://ajindex.com/articles/600109

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Aguiar CJ, Rocha-Franco JA, Sousa PA, Santos AK, Ladeira M et al. (2014). Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Communication and Signalling 12: 2-17. doi: 10.1186/s12964-014-0078-2
  2. Caggiano FM, Kamynina A, Francois AA, Prysyazhna O, Eykyn TR et al. (2020). Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy. Nature Metabolism. doi: 10.1038/s42255-020-00276-5
  3. Chong J, Wishart DS, Xia J (2019). Using MetaboAnalyst 4.0 for comprehensive and integrative data analysis. Current Protocols in Bioinformatics 68 (1): 1-128. doi: 10.1002/cpbi.86 Delafontaine P, Akao M (2006). Angiotensing II as candidate of cardiac cachexia. Current Opinion in Clinical Nutrition and Metabolic Care 9 (3): 220-224. doi: 10.1097/01. mco.0000222103.29009.70 Dhakal CP (2019). Interpreting the basic output (SPSS) of multiple linear regression. International Journal of Science and Research 8: 1448-1452. doi: 10.21275/4061901
  4. Doss VA, Kanniyappan S, Kuberapandian D (2019). Interventional effect of Piper betle aqueous extract in the progression of isoproterenol induced cardiac hypertrophy. International Journal of Pharmaceutical Research 11 (4): 216-220. doi: 10.31838/ijpr/2019.11.04.035 Doss VA, Kuberapandian D (2019). Evaluation of anti-hypertrophic potential of Enicostemma littorale Blume on isoproterenol induced cardiac hypertrophy. Indian Journal of Clinical Biochemistry. doi: 10.1007/s12291-019-0814-x Droge W, Gross A, Hack V, Kinscherf R, Schykowski M et al. (1997). Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine. Advances in Pharmacology 38: 581-600. doi: 10.1016/S1054- 3589(08)61000-5
  5. Edwards CW (1974). Left ventricular hypertrophy in emphysema Thorax 29 (1): 75-80. doi: 10.1136/thx.29.1.75 Finocchiaro G, Merio M, Sheikh N, Angelis GD, Papadakis M et al. (2020). The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. European Journal of Heart Failure 22: 1097-1107. doi: 10.1002/ ejhf.1815 Gibb AA, Hill BG (2017). Metabolic coordination of physiological and pathological cardiac remodeling. Circulation Research 123: 107-128. doi: 10.1161/CIRCRESAHA.118.312017
  6. Goonasekara CL, Balse E, Hatem S, Steele DF, Fedida D. (2010). Cholesterol and cardiac arrhythmias. Expert Review of Cardiovascular Therapy 8 (7): 965-979. doi: 10.1586/ERC.10.79 Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC (2002). Low ser